Nick Ferrari blasts Barry Gardiner over cancer patient remark
We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on our understanding. You can unsubscribe at any time. More info
It is this genetic makeup that scientists believe should be tracked in men and used as a marker for prostate cancer – one of the most common cancers in the UK – and the most prevalent in men.
Publishing their research in the British Journal of Cancer, the researchers from the University of Exeter examined the impact of incorporating genetic risk for cancer into referral processes.
They concluded that men with certain genetic profiles should be tracked for the disease and fast-tracked for investigation if their risk was considered too high. They also found genetic referrals could avoid the need for biopsy investigations for those with a low risk of cancer.
The reason why this could save lives is because prostate cancer doesn’t present with symptoms in its early stages, meaning it is very difficult to catch and treat early. Around 12,000 men die every year from the disease, the equivalent of one every 45 minutes.
Speaking about the research, the study’s lead author Doctor Sarah Bailey said: “This is potentially an exciting new strategy for early cancer detection. Not only can high risk patients be fast tracked, but those at low risk can safely avoid invasive investigations.
“Using this technique would align well to the NHS Long Term Plan, which pledges to become the first national health care system to offer whole genome sequencing as part of routine care. This could be a clear example of improving early diagnosis, and therefore treatment and survival.”
In recent years there has been greater focus around not just male cancer awareness, but diagnosis and a rise in calls for screenings to be expanded to men as well as women.
Currently, there is a thorough cervical cancer screening programme where women are called forward to be checked for signs of the disease so it can be treated early. Charities and other entities believe the same should be extended to men and male specific cancers.
Meanwhile, Kirsten Higgens, who funded the study added: “We’re delighted to be able to support the Exeter team to explore the application of genomics data in a more targeted approach to prostate cancer detection. It’s very exciting to see the real world benefit to patients of this innovative new approach.”
This isn’t the first time in 2022, that a new diagnostic tool for prostate cancer has been trialled out. Earlier this year, the charity Prostate Cancer UK launched their 30-second checker.
A three question questionnaire which takes around 30 seconds to complete, the online test provides men with their risk level; if their risk is above a certain point the site recommends to them a blood test which can be taken to establish their risk.
Unlike other male cancer campaigns, this promotional occurred outside of autumn, a time when much noise is made in the build-up to November and “Movember” when men grow out their moustaches to raise awareness of cancer.
What are the main symptoms of prostate cancer?
While prostate cancer doesn’t present with symptoms in its early stages, it can begin to cause signs when it has developed or spread to other areas of the body.
Symptoms to look out for include:
• Needing to pee more frequently
• Needing to rush to the toilet
• Straining or taking a long time while peeing
• Weak flow of pee
• Feeling that the bladder has not emptied fully
• Blood in urine
• Blood in semen.
While presence of these symptoms may seem unnerving, the NHS stresses that their presence “do not always mean you have prostate cancer”.
However, if these symptoms persist, it is essential men get checked. It is far better to get checked and to find it is nothing than to leave it and find out months on that something could have been done about it earlier.
Have prostate cancer figures been affected by the pandemic?
Undoubtedly, Prostate Cancer UK say they “still need to find thousands of men who have gone undiagnosed because of the pandemic”; it is for this reason that year-round awareness of prostate cancer is essential.
Why will cases have been missed?
It’s not that cases will have been missed, but rather that people would not have come forward. During the pandemic, the NHS had to divert almost all its resources towards COVID-19.
As a result, many people experiencing symptoms were afraid to come in for fear of putting undue pressure on the health service during the first wave. This was despite statements from the NHS encouraging people to keep coming forward if they had cancer symptoms or concerns.
Despite this, it is believed many didn’t; something which will result in thousands of cancers being diagnosed at later stages when they are much harder to treat effectively.
Source: Read Full Article